Cargando…

Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry

Introduction: Hospitalized patients with COVID-19 may have increased risk of venous thromboembolism (VTE) and pulmonary embolism (PE). Cancer and anti-cancer therapies are well-known additional risk factors for VTE. Nonetheless, the VTE risk in patients with both cancer and COVID-19 infection remain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ang, Kuderer, Nicole M., Warner, Jeremy L., Desai, Aakash, Shah, Dimpy P., Fu, Julie, Li, Monica, Zon, Rebecca, Shah, Surbhi, Gulati, Shuchi, Khaki, Ali Raza, Kulkarni, Amit, Elshoury, Amro, Thompson, Michael A., Grivas, Petros, de Lima Lopes, Gilberto, Shyr, Yu, Pennell, Nathan A, Schmidt, Andrew, Friese, Christopher R, Stover, Daniel, Patel, Jaymin, Halmos, Balazs, Choueiri, Toni K., Peters, Solange, Rivera, Donna R., Painter, Corrie, Rini, Brian, Lyman, Gary H., Connors, Jean M., Rosovsky, Rachel P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	904.Outcomes Research-Non-Malignant Conditions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330164/ http://dx.doi.org/10.1182/blood-2020-138834

Ejemplares similares

Bleeding Complications in Patients with Cancer and COVID 19- Analysis from the COVID 19and Cancer Consortium (CCC19) Registry
por: Shah, Surbhi, et al.
Publicado: (2021)

Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis
por: Rubinstein, Samuel, et al.
Publicado: (2020)

LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19)
por: Grivas, P., et al.
Publicado: (2020)

HTLV COMO FATOR DE RISCO E GRAVIDADE AO COVID-19 - RELATO DE DOIS CASOS
por: Carvalho, L.G., et al.
Publicado: (2020)

The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19
por: Li, Ang, et al.
Publicado: (2021)

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
por: Kuderer, Nicole M, et al.
Publicado: (2020)

Crowdsourcing a crisis response for COVID-19 in oncology
por: Desai, Aakash, et al.
Publicado: (2020)

Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry
por: Gavrilina, Olga A., et al.
Publicado: (2020)

Final Results of CHRONOS19 Observational Study in Patients with Hematologic Disease and COVID-19 in Russia
por: Gavrilina, Olga A., et al.
Publicado: (2021)

Implementation and Preliminary Effectiveness of mHealth Apps for Improving Sickle Cell Disease Care during COVID-19: A Mixed-Methods Evaluation
por: Badawy, Sherif M., et al.
Publicado: (2021)

Immature Platelets and Disease Severity in Patients Hospitalized with Acute COVID-19 Who Are Vaccinated Against COVID-19
por: Lee, Nicholas C.J., et al.
Publicado: (2021)

Prediction of COVID-19 Mortality in Patients with Cancer
por: Mantha, Simon, et al.
Publicado: (2020)

Thrombotic Complications in COVID-19 Patients: Low Incidence of Thrombotic Complications Among Critically Ill COVID-19 Patients in Singapore
por: Lim, Cheryl XQ, et al.
Publicado: (2020)

Incidence of Vascular Thromboembolic Events in Outpatients with Mild COVID-19
por: Eswaran, Harish, et al.
Publicado: (2020)

Assessment of Hematologic and Coagulation Parameters As Predictive Value in COVID-19 with Unfavourable Evolution
por: Popov, Viola Maria, et al.
Publicado: (2020)

Anticoagulant and Antiplatelet Use Not Associated with Improvement in Severe Outcomes in COVID-19 Patients
por: Ho, Gwendolyn, et al.
Publicado: (2020)

ABO Blood Type and Outcomes in a Diverse COVID-19 Infected Population
por: Paul, Sonal, et al.
Publicado: (2020)

Venous Thromboembolism Post-COVID-19 Among Individuals with Sickle Cell Disease
por: Singh, Ashima, et al.
Publicado: (2021)

Association of Blood Type on Clinical Outcomes in Black/African Americans Hospitalized for COVID-19 Infection
por: Cheng, Yan, et al.
Publicado: (2020)

Outcomes of Patients with Hematologic Malignancies and COVID-19: Perspective of a Large Hematology Center in Greece
por: Spyridis, Nikolaos, et al.
Publicado: (2021)

Clinical Course and Outcomes of Sickle Cell Disease Patients with COVID-19 at a New York Hospital
por: Mazloom, Anita, et al.
Publicado: (2020)

Pediatric Sickle Cell Disease and the COVID-19 Pandemic: A Year in Review at Children's National Hospital
por: Martin, Olufunke Y., et al.
Publicado: (2021)

Patient-Focused Benefits of at-Home Versus in-Clinic Administration of Cancer Therapy: New Considerations for the COVID-19 Era
por: Sandman, Karen E., et al.
Publicado: (2020)

ERN-EuroBloodNet European Registry of Patients Affected by Red Blood Cell Disorders and COVID-19
por: Velasco, Pablo, et al.
Publicado: (2021)

COVID-19 and Sickle Cell Disease in the Province of Quebec: Morbidity and Mortality Rates Derived from the Provincial Registry
por: Castonguay, Mathias, et al.
Publicado: (2021)

The Impact of ABO Blood Group on Clinical Outcomes and Susceptibility in COVID-19: A Retrospective Population Study of 3305 Patients
por: Alduaij, Waleed, et al.
Publicado: (2020)

Incidence of Thrombosis and Associated Risk Factors in Hospitalized COVID-19 Patients in a New York City Hospital System
por: Theprungsirikul, Poy P., et al.
Publicado: (2020)

Use of Monoclonal Antibody Therapy in Hematologic Patients with Mild-to-Moderate COVID-19: A Retrospective Single-Center Experience
por: Amanam, Idoroenyi, et al.
Publicado: (2021)

Comparison of Characteristics and Laboratory Tests of COVID 19-Hematological Patients from France and Brazil: Identification of Prognostic Driven Profiles
por: Alves, Lucas Bassolli de Oliveira, et al.
Publicado: (2021)

Ethnic Variation in Hospitalized COVID-19 Patients and Correlation with Coagulopathy, Thrombosis, Prognosis and 30 Day Mortality Outcomes in California's Central Valley
por: Huang, Charity A, et al.
Publicado: (2021)

Hematologic Characteristics of Surviving Versus Non-Surviving COVID-19 Patients in Critical Care Units: Inner-City Hospital Experience, Detroit, MI
por: Balanchivadze, Nino, et al.
Publicado: (2020)

Clinical Profile and Outcome of COVID Positive Hematology Patients during the COVID-19 Pandemic - an Analytical Cross Sectional Study from a Tertiary Care Centre in India
por: Kassim, Faisal, et al.
Publicado: (2021)

Four-Fold Increased Mortality from Sars-Cov-2 Infection in Patients with Hematologic Versus Non-Hematologic Malignancies Treated at the Largest Tertiary COVID-19 Center in Chicago/Rush University Medical Center (March 1, 2020-December 31,2020)
por: Yun, Nicole K., et al.
Publicado: (2021)

LBA71 Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis
por: Wise-Draper, T.M., et al.
Publicado: (2020)

Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study
por: Satyanarayana, Gowri, et al.
Publicado: (2022)

Real World Outcomes of Sars-Cov-2 Thrombosis Rates across Three University Health Systems in the Chicago Metropolitan Area
por: Berg, Stephanie, et al.
Publicado: (2020)

COVID Vaccination Rates in Children and Adults with Sickle Cell Disease in British Columbia, Canada
por: Merkeley, Hayley, et al.
Publicado: (2021)

Comparison of Clinical and Thrombotic Outcomes in Sars-Cov-2- Pneumonia Versus Other Viral Pneumonia in an Urban Academic Medical Center
por: Goldberg, Rachel N., et al.
Publicado: (2021)

Middle East Respiratory Syndrome (MERS) Infection in Hematological and Oncological Patients: A Case Series from a Tertiary Care Center in Saudi Arabia
por: Alaskar, Ahmed, et al.
Publicado: (2019)

CLINICAL CHARACTERISTICS AND OUTCOMES IN CARDIO-ONCOLOGY PATIENTS WITH COVID-19: ANALYSIS FROM THE COVID-19 AND CANCER CONSORTIUM (CCC19) DATABASE
por: Moey, Melissa YY, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3dcst0nfesdskruc8gfdfsr0v5